 <h1>Persantine IV Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>dipyridamole</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about dipyridamole. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Persantine IV.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to dipyridamole: solution, tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, dipyridamole (the active ingredient contained in Persantine IV) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>Check with your doctor as soon as possible if any of the following side effects occur while taking dipyridamole:</p><p>
<i>Rare</i>
</p><ul>
<li>Chest pain</li>
<li>gallstones</li>
<li>tightness or swelling of neck</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of dipyridamole may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal or stomach cramps</li>
<li>diarrhea </li>
<li>dizziness or lightheadedness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Flushing</li>
<li>headache</li>
<li> nausea or vomiting</li>
<li>weakness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>General discomfort and/or unusual tiredness or weakness</li>
<li>hair loss</li>
<li>joint pain or swelling</li>
<li>muscle pain</li>
<li>runny nose</li>
<li>sneezing</li>
</ul><p>
<!-- end solution, tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to dipyridamole: compounding powder, intravenous solution, oral tablet</i></p><h3>General</h3><p>The most frequent adverse reactions were chest pain/angina pectoris, electrocardiographic changes (mostly ST-T changes), headache, and dizziness.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Chest pain/angina pectoris (19.7%), electrocardiographic changes (15.9%)</p>
<p><b>Common</b> (1% to 10%): Electrocardiographic abnormalities/ST-T changes, electrocardiographic abnormalities/extrasystoles, hypotension, flushing, electrocardiographic abnormalities/tachycardia, blood pressure lability, hypertension, angina pectoris, bleeding</p>
<p><b>Uncommon</b> (0.1% to 1%): Myocardial infarction, electrocardiographic abnormalities unspecified, arrhythmia unspecified, palpitation, ventricular tachycardia, bradycardia, atrioventricular block, orthostatic hypotension, atrial fibrillation, supraventricular tachycardia</p>
<p><b>Rare</b> (0.01% to 0.1%): Fatal myocardial infarction, nonfatal myocardial infarction, ventricular arrhythmia unspecified, heart block unspecified, cardiomyopathy, intermittent claudication</p>
<p><b>Very rare</b> (less than 0.01%): Asystole, sustained ventricular tachycardia or ventricular fibrillation</p>
<p><b>Frequency not reported</b>: Bleeding during or after surgery, cardiac death, ventricular fibrillation, symptomatic ventricular tachycardia, sinus node arrest, sinus node depression, conduction block, tachycardia, post procedural hemorrhage, operative hemorrhage, cardiac arrest, sinus arrest</p>
<p><b>Postmarketing reports</b>: Palpitation<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea</p>
<p><b>Uncommon</b> (0.1% to 1%): Severe bronchospasm, pharyngitis, bronchospasm, hyperventilation, rhinitis</p>
<p><b>Rare</b> (0.01% to 0.1%): Dysphonia, coughing, pleural pain</p>
<p><b>Very rare</b> (less than 0.01%): Pulmonary edema</p>
<p><b>Frequency not reported</b>: Laryngospasm</p>
<p><b>Postmarketing reports</b>: Larynx edema<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 37.2%), dizziness (up to 30.1%)</p>
<p><b>Common</b> (1% to 10%): Paresthesia</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypoesthesia, hypertonia, tremor, tinnitus, dysgeusia</p>
<p><b>Rare</b> (less than 0.1%): Abnormal coordination, somnolence, migraine, vertigo, transient ischemic attack</p>
<p><b>Frequency not reported</b>: Stroke, transient cerebral ischemia, seizures, cerebrovascular accident, syncope, cerebral seizure/grand mal seizure<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dyspepsia (up to 16.6%), diarrhea (up to 15.4%), nausea (up to 14.8%), gastric pain (up to 14.5%)</p>
<p><b>Common</b> (1% to 10%): Abdominal distress, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Dry mouth, abdominal pain, flatulence, eructation</p>
<p><b>Rare</b> (less than 0.1%): Dysphagia, tenesmus</p>
<p><b>Frequency not reported</b>: Gastroduodenal ulcer<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Pain unspecified, fatigue</p>
<p><b>Uncommon</b> (0.1% to 1%): Asthenia, malaise, earache</p>
<p><b>Rare</b> (less than 0.1%): Death, any complication<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia</p>
<p><b>Uncommon</b> (0.1% to 1%): Back pain, arthralgia, rigor</p>
<p><b>Rare</b> (less than 0.1%): Leg cramping</p>
<p><b>Postmarketing reports</b>: Arthritis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Diaphoresis</p>
<p><b>Frequency not reported</b>: Pruritus, urticaria</p>
<p><b>Postmarketing reports</b>: Alopecia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity reaction</p>
<p><b>Frequency not reported</b>: Anaphylactoid reaction, angioedema</p>
<p><b>Postmarketing reports</b>: Allergic reaction, urticaria, pruritus, dermatitis, rash<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Nervousness/anxiety</p>
<p><b>Rare</b> (less than 0.1%): Depersonalization<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Vision abnormalities unspecified</p>
<p><b>Rare</b> (less than 0.1%): Eye pain<sup>[Ref]</sup></p><h3>Local</h3><p><b>Uncommon</b> (0.1% to 1%): Injection site reaction unspecified, injection site pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Rare</b> (less than 0.1%): Edema, appetite increased, thirst<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Rare</b> (less than 0.1%): Breast pain<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Rare</b> (less than 0.1%): Perineal pain<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (less than 0.1%): Renal pain<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Thrombocytopenia, anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Liver dysfunction</p>
<p><b>Postmarketing reports</b>: Hepatitis, cholelithiasis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Rash, urticaria, severe bronchospasm, angioedema<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Persantine (dipyridamole)." Boehringer-Ingelheim, Ridgefield, CT. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Persantine IV (dipyridamole)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: cardiac stressing agents</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Persantine</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Prosthetic Heart Valves - Thrombosis Prophylaxis</li>
<li>Radionuclide Myocardial Perfusion Study</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to dipyridamole: compounding powder, intravenous solution, oral tablet</i></p><h3>General</h3><p>The most frequent adverse reactions were chest pain/angina pectoris, electrocardiographic changes (mostly ST-T changes), headache, and dizziness.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Chest pain/angina pectoris (19.7%), electrocardiographic changes (15.9%)</p><p><b>Common</b> (1% to 10%): Electrocardiographic abnormalities/ST-T changes, electrocardiographic abnormalities/extrasystoles, hypotension, flushing, electrocardiographic abnormalities/tachycardia, blood pressure lability, hypertension, angina pectoris, bleeding</p><p><b>Uncommon</b> (0.1% to 1%): Myocardial infarction, electrocardiographic abnormalities unspecified, arrhythmia unspecified, palpitation, ventricular tachycardia, bradycardia, atrioventricular block, orthostatic hypotension, atrial fibrillation, supraventricular tachycardia</p><p><b>Rare</b> (0.01% to 0.1%): Fatal myocardial infarction, nonfatal myocardial infarction, ventricular arrhythmia unspecified, heart block unspecified, cardiomyopathy, intermittent claudication</p><p><b>Very rare</b> (less than 0.01%): Asystole, sustained ventricular tachycardia or ventricular fibrillation</p><p><b>Frequency not reported</b>: Bleeding during or after surgery, cardiac death, ventricular fibrillation, symptomatic ventricular tachycardia, sinus node arrest, sinus node depression, conduction block, tachycardia, post procedural hemorrhage, operative hemorrhage, cardiac arrest, sinus arrest</p><p><b>Postmarketing reports</b>: Palpitation<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea</p><p><b>Uncommon</b> (0.1% to 1%): Severe bronchospasm, pharyngitis, bronchospasm, hyperventilation, rhinitis</p><p><b>Rare</b> (0.01% to 0.1%): Dysphonia, coughing, pleural pain</p><p><b>Very rare</b> (less than 0.01%): Pulmonary edema</p><p><b>Frequency not reported</b>: Laryngospasm</p><p><b>Postmarketing reports</b>: Larynx edema<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 37.2%), dizziness (up to 30.1%)</p><p><b>Common</b> (1% to 10%): Paresthesia</p><p><b>Uncommon</b> (0.1% to 1%): Hypoesthesia, hypertonia, tremor, tinnitus, dysgeusia</p><p><b>Rare</b> (less than 0.1%): Abnormal coordination, somnolence, migraine, vertigo, transient ischemic attack</p><p><b>Frequency not reported</b>: Stroke, transient cerebral ischemia, seizures, cerebrovascular accident, syncope, cerebral seizure/grand mal seizure<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dyspepsia (up to 16.6%), diarrhea (up to 15.4%), nausea (up to 14.8%), gastric pain (up to 14.5%)</p><p><b>Common</b> (1% to 10%): Abdominal distress, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Dry mouth, abdominal pain, flatulence, eructation</p><p><b>Rare</b> (less than 0.1%): Dysphagia, tenesmus</p><p><b>Frequency not reported</b>: Gastroduodenal ulcer<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Pain unspecified, fatigue</p><p><b>Uncommon</b> (0.1% to 1%): Asthenia, malaise, earache</p><p><b>Rare</b> (less than 0.1%): Death, any complication<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia</p><p><b>Uncommon</b> (0.1% to 1%): Back pain, arthralgia, rigor</p><p><b>Rare</b> (less than 0.1%): Leg cramping</p><p><b>Postmarketing reports</b>: Arthritis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><p><b>Uncommon</b> (0.1% to 1%): Diaphoresis</p><p><b>Frequency not reported</b>: Pruritus, urticaria</p><p><b>Postmarketing reports</b>: Alopecia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity reaction</p><p><b>Frequency not reported</b>: Anaphylactoid reaction, angioedema</p><p><b>Postmarketing reports</b>: Allergic reaction, urticaria, pruritus, dermatitis, rash<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Nervousness/anxiety</p><p><b>Rare</b> (less than 0.1%): Depersonalization<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Vision abnormalities unspecified</p><p><b>Rare</b> (less than 0.1%): Eye pain<sup>[Ref]</sup></p><h3>Local</h3><p><b>Uncommon</b> (0.1% to 1%): Injection site reaction unspecified, injection site pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Rare</b> (less than 0.1%): Edema, appetite increased, thirst<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Rare</b> (less than 0.1%): Breast pain<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Rare</b> (less than 0.1%): Perineal pain<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (less than 0.1%): Renal pain<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Thrombocytopenia, anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Liver dysfunction</p><p><b>Postmarketing reports</b>: Hepatitis, cholelithiasis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Rash, urticaria, severe bronchospasm, angioedema<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Persantine (dipyridamole)." Boehringer-Ingelheim, Ridgefield, CT. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Persantine IV (dipyridamole)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: cardiac stressing agents</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Persantine</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Prosthetic Heart Valves - Thrombosis Prophylaxis</li>
<li>Radionuclide Myocardial Perfusion Study</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>